Sign In

Matthew Hewitt

Vice President, CTO Manufacturing Business Division at Charles River Laboratories

Matthew Hewitt is a seasoned professional with vast research experience in target & drug discovery, in vivo/in vitro model & assay development, tumor immunology/microenvironment, autologous/allogeneic/syngeneic rodent oncology models, CAR T-cells, AAV gene therapy/immunology, bioengineering, upper airway physiology, and neurobiology. With over 15 years of experience, he has authored numerous manuscripts, technical papers, and abstracts for high impact journals and presented data at national and international meetings. Matthew has a strong managerial background, with over 10 years of experience mentoring junior staff. He also possesses regulatory expertise, having written reports for FDA and European Medical Authority filings as well as patents in the US and EU.

Highlights

Mar 11 · youtube.com
Matthew Hewitt: scalability is a collective problem - YouTube
Matthew Hewitt: scalability is a collective problem - YouTube
Nov 15 · oribiotech.com
Ori Biotech LEAPs forward toward commercialization in 2024

Related Questions

What are Matthew Hewitt's main responsibilities at Charles River Laboratories?
How has Matthew Hewitt contributed to the advancement of cell and gene therapy?
What is the significance of Matthew Hewitt's role on Ori Biotech's Strategic Advisory Board?
Can you provide more details about the Ori Biotech LEAP program?
What are the key achievements of Matthew Hewitt in the CGT sector?
Matthew Hewitt
Matthew Hewitt, photo 1
Matthew Hewitt, photo 2
Add to my network

Location

Wilmington, Massachusetts, United States